Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.9 HKD | -0.14% | +27.14% | -28.92% |
Apr. 12 | Keymed Biosciences Advances Solid Tumors Drug With First Patient Study | MT |
Mar. 27 | KeyMed Biosciences’ Attributable Loss Widens in 2023 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.92% | 1.24B | |
-2.08% | 103B | |
+0.52% | 95.71B | |
+1.69% | 22.02B | |
-16.73% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-15.00% | 15.52B | |
+3.78% | 13.86B | |
+34.30% | 12.04B |
- Stock Market
- Equities
- 2162 Stock
- News Keymed Biosciences Inc.
- Keymed Biosciences Completes Data Unblinding for Phase 3 Study of Eczema Treatment; Shares Rise 8%